ARTA
ONCY

A.R.T. Advisors’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

A.R.T. Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,203
Closed -$17K – 1737
2013
Q4 		$17K Buy
+11,203
New +$25.2K ﹤0.01% 1239

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $62.7B AUM 37.65% 1-Year Est. Return

A.R.T. Advisors's ONCY Position: Q1 2014 in Review

A.R.T. Advisors sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2014, closing a stake of 11,203 shares — an estimated $17K sold.

A.R.T. Advisors first reported a position in ONCY in Q4 2013 and held it in 1 quarter. The position peaked at $17K in Q4 2013. 34 funds tracked by Wall St. Rank hold ONCY as of Q1 2014.

  • A.R.T. Advisors reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2014 after selling out during the quarter.
  • A.R.T. Advisors sold 11,203 ONCOLYTICS BIOTECH INC shares in Q1 2014, an estimated $17K.
  • A.R.T. Advisors first reported a position in ONCOLYTICS BIOTECH INC in Q4 2013 and held it in 1 quarter.
  • A.R.T. Advisors's ONCOLYTICS BIOTECH INC position peaked at $17K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2014.

Based on A.R.T. Advisors's 13F filing for Q1 2014, filed 15 May 2014.